Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Cirrhosis
Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis With Thrombocytopenia
Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis
Hemolysis in Patients With Hereditary Spherocytosis (HS)
|5||Not yet recruiting||
Study of Efficacy and Safety of INC424 in Regularly Transfused Patients With Thalassemia.
† Indicates status has not been verified in more than two years